About
The Virginia Biosciences Commercialization Center (VBCC), a wholly owned subsidiary of Virginia Life Science Investments, LLC (VLSI), develops and leads implementation of tailored commercialization strategies for later-stage bioscience companies looking to launch their product(s) in the U.S. and other markets. This comprehensive program surrounds each company with scientific, clinical and industry experts focused on every facet of the commercialization process, assuring effective scale-up and maximization of enterprise value. Virginia Life Science Investments, LLC, the Commercialization Center’s parent company, can provide financial support for realization of significant commercialization milestones. Each company represents an attractive investment opportunity, as they are thoroughly screened, later-state companies with market ready and market validated technologies that, once in the program, are strategically surrounded by industry experts.
Investment Focus
- Location
- Richmond, US
Contact Information
Find more investors like Virginia
Search Investors